Is Ceritinib/Ceritinib a targeted drug for ALK lung cancer?

Ceritinib/Ceritinib (Ceritinib) is a targeted drug for ALK (tyrosine kinase) fusion-positive non-small cell lung cancer (NSCLC). ALK Fusion-positive NSCLC is a specific subtype of lung cancer. The ALK gene and other gene fusions exist in its cancer cells, resulting in abnormal activity of ALK kinase, promoting the growth and spread of cancer cells.

Ceritinib/Ceritinib works by inhibiting the activity of this abnormal ALK fusion protein, blocking the proliferation and spread of cancer cells, thereby inhibiting the development of tumors. This targeted drug is designed to target specific mutations in tumor cells and reduce the impact on normal cells, thereby improving the effectiveness of treatment and reducing side effects.

The application of ceritinib/ceritinib has shown significant efficacy in ALKfusion-positive NSCLC patients, especially those who are ineffective or resistant to traditional chemotherapy. It provides a new, more targeted treatment option for ALKfusion-positive NSCLC patients, resulting in better prognosis and quality of life.

However, like all medicines, ceritinib/ceritinib may cause some side effects. Therefore, while using ceritinib/ceritinib, patients should strictly follow the doctor's recommendations and medication instructions, conduct regular review and monitoring, and promptly report any new symptoms or discomfort to the doctor to ensure the safety and effectiveness of the treatment.

CurrentlyCeritinib/Ceritinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. Although Ceritinib/Ceritinib has been included in medical insurance, the price is still very high. The domestic price ranges from 12,600 to 24,000. Different specifications have different prices. Please consult your local pharmacy for details. Foreign original drugs are divided into original drugs and generic drugs. Foreign original drugs are mainly Swiss Novartis original drugs. Specification150mg*150The price is about13,500 yuan. Generic drugs mainly include Bangladeshi version, with specifications of 150mg*30 and the price is around 1,300 yuan. The ingredients of original drugs and generic drugs are basically the same.